Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: ISTA Pharmaceuticals, Inc.
Current Parent Company: Bausch Health
Penalty: $390,253
Year: 2013
Date: May 24, 2013
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: kickbacks and bribery
Violation Description: ISTA Pharmaceuticals agreed to pay $390,253 to settle multistate litigation alleging that it promoted the sale and use of its drug Xibrom for uses not approved by the Food and Drug Administration and paid kickbacks to healthcare professionals, thus causing false claims to be submitted to state Medicaid programs. This was part of a larger $33.5 million civil and criminal settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Canada
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.